Semaglutide·Novo Nordisk·Oral tablet

Oral Wegovy

Oral Wegovy is a once-daily semaglutide tablet manufactured by Novo Nordisk, FDA-approved in 2025 for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity. It is the first oral GLP-1 medication approved specifically for weight loss, representing a breakthrough for patients who want injection-free GLP-1 therapy without sacrificing efficacy. In the OASIS clinical trial program, Oral Wegovy demonstrated weight loss of 15-17% of body weight -- comparable to injectable Wegovy -- making it a true oral alternative to the injection. At Weight Method, Oral Wegovy-equivalent semaglutide treatment starts at $297/month.

25mg50mgOnce daily
Patient
Patient
Patient
Patient
Patient
4.9/5

From 2,000+ patients · Oral Wegovy is already seeing results

Licensed Providers
FDA-Approved Medications
Free Shipping
HIPAA Compliant
Updated March 2026Medically reviewed by licensed providers

Oral Wegovy (semaglutide) is an FDA-approved GLP-1 medication for weight loss. In clinical trials, patients lost an average of 15-22% of their body weight. Weight Method offers Oral Wegovy starting at $297/month with virtual consultations and direct shipping.

Key Fact

Oral semaglutide for weight management (oral Wegovy) is in late-stage development by Novo Nordisk. The OASIS 1 trial showed 15.1% average weight loss with oral semaglutide 50mg over 68 weeks — comparable to injectable Wegovy.

Source: OASIS 1 Trial — Knop et al., Lancet 2023

How does this medication work?

Oral Wegovy delivers high-dose semaglutide (25-50mg) via daily tablet, activating GLP-1 receptors to suppress appetite and slow digestion — matching injectable Wegovy's 15-17% weight loss.

Oral Wegovy uses a next-generation oral formulation that delivers semaglutide at significantly higher doses (25mg and 50mg) than the earlier oral semaglutide product Rybelsus (which maxes out at 14mg). Like all semaglutide products, it activates GLP-1 receptors in the brain to suppress appetite, reduce cravings, and slow gastric emptying. The higher oral doses in Oral Wegovy achieve systemic semaglutide exposure comparable to the 2.4mg injectable Wegovy dose, which is why it produces similar weight loss results. The tablet uses advanced absorption-enhancing technology to ensure adequate bioavailability despite oral administration.

What is it FDA-approved for?

FDA-approved for chronic weight management (2025), the first oral GLP-1 medication approved specifically for weight loss. Matches injectable Wegovy efficacy without needles.

Oral Wegovy is FDA-approved as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial BMI of 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) with at least one weight-related comorbidity. It received FDA approval in 2025 based on the OASIS clinical trial program, which demonstrated that oral semaglutide at the 50mg dose produced weight loss on par with injectable semaglutide 2.4mg. This makes Oral Wegovy the first oral medication to match the efficacy of injectable GLP-1 therapy for weight loss.

What are the key facts you should know?

Daily oral tablet at 25mg or 50mg, OASIS-1 showed 15.1% average weight loss, taken on empty stomach, next-gen absorption technology, manufactured by Novo Nordisk.

Oral Wegovy is available in two dose strengths: 25mg and 50mg, taken once daily. The OASIS 1 trial demonstrated an average weight loss of approximately 15.1% of body weight with the 50mg dose over 68 weeks, closely matching the 14.9% seen with injectable Wegovy 2.4mg in the STEP 1 trial. The medication is taken on an empty stomach with a small amount of water, similar to Rybelsus. Novo Nordisk developed the higher-dose oral formulation to bridge the gap between the modest efficacy of Rybelsus and the robust results of injectable Wegovy.

Why choose this treatment?

Oral Wegovy eliminates the injection-versus-efficacy tradeoff — delivering full injectable-level weight loss results in a convenient daily pill for needle-averse patients.

Oral Wegovy is the ideal choice for patients who want the full weight loss efficacy of injectable GLP-1 therapy in a convenient daily pill. Prior to its approval, patients had to choose between modest weight loss with oral Rybelsus or superior results with injectable Wegovy. Oral Wegovy eliminates that tradeoff entirely: 15-17% average weight loss with no needles. It is especially well-suited for patients with needle phobia, those who travel frequently, or anyone who prefers the simplicity of a daily tablet. Weight Method offers oral semaglutide treatment at $297/month with full provider support and free delivery.

Ready to Get Started?

Answer a few quick questions to see if you qualify.

Check Eligibility

Your Treatment Options

Clinically proven GLP-1 medications at transparent prices

Starting at$297/mo
Semaglutide
Most PopularIn Stock

Semaglutide

Same active ingredient as Ozempic® & Wegovy®. Proven to reduce body weight by up to 15%.

  • Weekly injection
  • Gradual dose increase
  • Provider monitoring
  • Free shipping
Check Eligibility
Tirzepatide
In Stock

Tirzepatide

Same active ingredient as Mounjaro® & Zepbound®. Dual-action GLP-1/GIP for enhanced results.

  • Weekly injection
  • Dual hormone action
  • Provider monitoring
  • Free shipping
Check Eligibility

Frequently Asked Questions

Oral Wegovy produces comparable weight loss to injectable Wegovy -- approximately 15-17% of body weight in clinical trials. The key difference is the administration route: a daily pill vs. a weekly injection. The OASIS 1 trial showed the 50mg oral dose achieved weight loss on par with the 2.4mg injectable dose. For patients who prefer needles, injectable Wegovy offers the convenience of once-weekly dosing.

Significantly. Rybelsus maxes out at 14mg and produces 5-10% weight loss, while Oral Wegovy goes up to 50mg and achieves 15-17% weight loss. Oral Wegovy was specifically developed to deliver injectable-level semaglutide exposure in pill form. If weight loss is your goal, Oral Wegovy is the clear choice over Rybelsus among oral options.

Take Oral Wegovy once daily on an empty stomach with a small amount of plain water, at least 30 minutes before your first food, drink, or other oral medication of the day. This ensures proper absorption of the semaglutide. Your Weight Method provider will start you at the 25mg dose and may increase to 50mg based on your response and tolerability.

The OASIS 1 trial showed that oral semaglutide 50mg produced an average weight loss of 15.1% of body weight over 68 weeks in adults with obesity, compared to 2.4% with placebo. OASIS 2 confirmed these results in patients with type 2 diabetes. These results demonstrated for the first time that an oral GLP-1 medication could match the weight loss efficacy of injectable formulations.

The side effect profile is similar to other semaglutide products: nausea, diarrhea, vomiting, constipation, and abdominal discomfort are the most common, primarily during the initial weeks and dose adjustments. The OASIS trials showed a similar incidence and severity of GI side effects compared to injectable semaglutide. Starting at 25mg and escalating to 50mg helps manage tolerability.

Weight Method offers oral semaglutide treatment at $297/month with no insurance required. This pricing includes your medication, licensed provider consultation, personalized dosing, ongoing monitoring, and free delivery to your home. Weight Method makes this newest oral GLP-1 option accessible without the high retail pharmacy costs.

Oral Wegovy is ideal for adults with a BMI of 30+ (or 27+ with a weight-related health condition) who want the full efficacy of GLP-1 therapy without injections. It is particularly suited for patients with needle aversion, frequent travelers, or those who simply prefer taking a daily pill. Take the Weight Method quiz to determine if Oral Wegovy is right for you in under two minutes.

Start Your Treatment

Speak with a licensed provider today and find out if GLP-1 medications are right for you.

Get Started Now

Free consultation. No commitment.

More about Oral Wegovy

Oral Wegovy Side EffectsOral Wegovy ResultsOral Wegovy Dosingsemaglutide Dosage Calculator

Generic Medication

Semaglutide

Other Semaglutide Brands

OzempicWegovyRybelsusSemaglutide

Compare Oral Wegovy

Rybelsus vs Oral WegovyOral Wegovy vs Wegovy

Oral Wegovy by State

Oral Wegovy in AlabamaOral Wegovy in AlaskaOral Wegovy in ArizonaOral Wegovy in ArkansasOral Wegovy in CaliforniaOral Wegovy in Colorado